This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CooperVision Announces FDA Special 510(K) Clearance On Avaira® Toric Contact Lenses

PLEASANTON, Calif., April 5, 2012 /PRNewswire/ -- CooperVision, Inc. today announced that the U.S. Food and Drug Administration has granted a Special 510(k) clearance for CooperVision's Avaira® Toric two-week silicone hydrogel contact lenses for astigmatism. Avaira® Toric highlights CooperVision's commitment to provide eye care practitioners with a choice within the two-week modality segment for their patients. CooperVision will re-launch Avaira® Toric with shipments available for select distribution beginning early May 2012.

CooperVision's Avaira® Toric silicone hydrogel contact lenses offer patients a consistently comfortable lens wearing experience. Avaira® Toric contact lenses also have an optimized ballast design for lens stability providing patients with excellent visual acuity. The consistent fit across the power range offers eye care practitioners a great option for a wide range of astigmatic patients.

Avaira® contact lenses are designed with an innate ability to attract and retain moisture within the lens material without the need for surface treatment or wetting agents. This is thanks to AQUAFORM® Comfort Science™ which makes it the only two-week silicone hydrogel toric that is uniquely naturally wettable. This technology provides comfort that patients can rely on day after day throughout the entire wearing cycle.

About CooperVision CooperVision, a unit of The Cooper Companies, Inc. (NYSE: COO), is one of the world's leading manufacturers of soft contact lenses. The Company produces a full array of monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges; such as astigmatism, presbyopia, and ocular dryness; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, thereby creating real advantages for customers and wearers. For more information, visit  www.coopervision.com .

SOURCE CooperVision

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs